12/4/2007 11:06:06 AM
HOUSTON--(BUSINESS WIRE)--Edgeline Holdings, Inc. (OTCBB:ELHI) announced today that it has completed the acquisition of Intertech Bio Corporation. Intertech Bio currently focuses on developing novel cancer treatments specifically targeting the brain, pancreatic and ovarian tumors. Intertech Bio will be moving to offices near the Texas Medical Center in Houston, Texas which is home to some of the most premier cancer treatment centers in the world.
comments powered by